Gritstone bio, Inc. (GRTS)

Gritstone bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	65.29	59.48	104.57	170.06	57.41
Short-Term Investments	16.29	116.39	108.35	1	70.37
Cash & Cash Equivalents	81.57	175.86	212.92	171.06	127.78
Cash Growth	-53.62%	-17.40%	24.47%	33.87%	-16.55%
Other Current Assets	5.86	7.01	7.67	4.33	3.5
Total Current Assets	87.44	182.88	220.59	175.39	131.27
Property, Plant & Equipment	84.12	38.82	44.54	43.45	50.34
Long-Term Investments	5.29	9.32	10.62	0.99	0
Other Long-Term Assets	0.92	9.74	2.35	1.74	2.78
Total Long-Term Assets	90.33	57.88	57.52	46.18	53.12
Total Assets	177.77	240.75	278.11	221.57	184.39
Accounts Payable	3.82	8.69	4.23	9.58	4.62
Deferred Revenue	2.35	5.13	20.33	11.7	14.52
Current Debt	6.9	5.29	7.48	5.87	2.51
Other Current Liabilities	14.27	15.68	7.91	-0.16	-2.14
Total Current Liabilities	27.34	34.8	39.96	26.99	19.5
Long-Term Debt	97.87	35.02	18.94	19.23	20.99
Other Long-Term Liabilities	0.71	0.15	3.13	8.62	9.56
Total Long-Term Liabilities	98.58	35.17	22.06	27.84	30.55
Total Liabilities	125.92	69.97	62.02	54.83	50.05
Total Debt	104.78	40.32	26.42	25.1	23.49
Debt Growth	159.88%	52.60%	5.26%	6.85%	123.93%
Retained Earnings	-659.56	-521.07	-401.38	-326.3	-220.99
Comprehensive Income	0	-0.08	-0.07	0	0.02
Shareholders' Equity	51.85	170.78	216.09	166.74	134.34
Net Cash / Debt	-23.2	135.55	186.5	145.96	104.29
Net Cash / Debt Growth	-	-27.32%	27.77%	39.96%	-26.88%
Net Cash Per Share	-0.20	1.49	2.36	3.86	3.11
Working Capital	60.1	148.08	180.63	148.4	111.77
Book Value Per Share	0.45	1.88	2.74	4.41	4.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).